The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) has granted Three-Year Accreditation to Sarah Cannon at Menorah Medical Center. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive patient-centered care.
Menorah Medical Center—part of HCA Midwest Health, Kansas City’s leading healthcare provider—is part of the Sarah Cannon HCA Midwest Health cancer network, providing local access to innovative clinical research trials, tumor profiling and genetic counseling; allowing patients to receive top, state-of-the-art cancer care close to home. Other Sarah Cannon HCA Midwest Health accredited cancer programs include Sarah Cannon at Belton Regional Medical Center, Accredited Associate Cancer Program; Sarah Cannon at Centerpoint Medical Center, Accredited Community Cancer Program; and Sarah Cannon at Research Medical Center, Accredited Comprehensive Cancer Program.
As a CoC-accredited cancer center, Sarah Cannon at Menorah Medical Center provides comprehensive patient-centered care through a multidisciplinary team approach. Cancer is treated as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary partnership results in improved patient care.
“We are pleased to be recognized as an innovative facility that offers a high level of cancer care to our patients,” says Menorah Medical Center Chief Executive Officer Charles Laird. “We offer patients and their families access to some of the most progressive physician specialists, nurse navigation and programs in the country that help make a cancer journey less complex and confusing.”
The CoC Accreditation Program provides the framework for Sarah Cannon at Menorah Medical Center to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease and end-of-life care. When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling, and patient centered services including psycho-social support, a patient navigation process, and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.
Like all CoC-accredited facilities, Sarah Cannon at Menorah Medical Center maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society (ACS). This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care. CoC-accredited cancer centers, in turn, have access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports. These reports help CoC facilities with their quality improvement efforts.
There are currently more than 1,500 CoC-accredited cancer programs in the U.S. and Puerto Rico, representing 30 percent of all hospitals. CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients.
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons. For more information, visit: www.facs.org/cancer.
For more information on Sarah Cannon at Menorah Medical Center, visit MenorahMedicalCenter.com.